Global Hybrid Grafts Market Projected to Reach USD 858.7 Million by 2032, Expanding at a CAGR of 5.20%

The global hybrid grafts market is set for significant growth, with a projected valuation of USD 517.3 million by the end of 2022. The market is anticipated to expand further at a compound annual growth rate (CAGR) of 5.20% from 2022 to 2032, reaching approximately USD 858.7 million by the end of the forecast period.

Hybrid grafts, which combine biological and synthetic materials, are increasingly being adopted in various surgical procedures due to their unique advantages, including improved biocompatibility, enhanced healing, and reduced risk of complications. As healthcare providers continue to seek innovative solutions for complex surgical challenges, the demand for hybrid grafts is expected to rise.

According to industry analysts, key factors contributing to this market growth include:

• Increasing Surgical Procedures: The rise in the number of surgeries, particularly cardiovascular and orthopedic procedures, is driving the demand for advanced grafting solutions.
• Technological Advancements: Innovations in graft design and material science are enhancing the efficacy and safety profiles of hybrid grafts, making them a preferred choice among surgeons.
• Growing Awareness: Increased awareness of the benefits of hybrid grafts among healthcare professionals and patients is further fueling market expansion.

Furthermore, prominent market participants are concentrating on developing novel products with increased efficacy, such as environmental stability, infection resistance, and durability. BD Interventional, for example, just launched Distaflo, which combines ePTFE with carbon soaked into the interior parts of the graft wall, as well as a patented cuff at the distal end.

Key Takeaways: Hybrid Grafts Market

• The thoracic aortic graft segment represented roughly 78.2% of the market share in 2021 and is expected to dominate the global Hybrid Grafts market by 2032.
• The hospitals sector is estimated to lead the worldwide Hybrid Grafts market with a 5.9% CAGR during the forecast period.
• The North America Hybrid Grafts market is expected to generate 42.1% in 2021 and will continue to lead in the coming years.
• With the expansion of the healthcare business, China is expected to hold a market share of almost 3.8% in 2032.
• Germany Hybrid Grafts market held a 3.5% share in 2021 and is expected to remain at the forefront during the evaluation period.

“Rising use of minimally invasive devices in medical procedures is set to drive the Hybrid Grafts market. Besides, increasing number of cardiac and vascular surgeries is anticipated to push demand for Hybrid Grafts to reduce surgical site complications,” says a FMI analyst.

Market Competition

The market for Hybrid Grafts is moderately fragmented and there exists a large number of local, emerging, as well as established players across the globe. Key players are initiating promotional activities to introduce new designs to attract more customers. A few other companies are engaging in collaborations and expansion activities to develop innovative products.

• In October 2021, Terumo collaborated with Cell Technologies to construct a new production facility in Costa Rica, which will support the company’s global supply chain.
• In May 2022, Getinge invested 3 million Euros to increase its capacity for producing polyester grafts and patches for the treatment of aneurysmal and occlusive illnesses. The investment would enable the company to increase manufacturing capacity at its La Ciotat, France, plant.

Key Players

• Terumo Corporation
• BD Interventional
• Getinge AB
• Merit Medical Systems, Inc.
• JOTEC GmbH

A Full Report Overview

More Valuable Insights on Hybrid Grafts Market

Future Market Insights offers a unique perspective and actionable insights on the Hybrid Grafts market in its latest study, presenting a historical demand assessment of 2017 to 2021 and projections for 2022 to 2032.

The research study is based on the product (thoracic aortic graft and peripheral vascular graft) and end user (hospitals and ambulatory surgical centers), across seven key regions of the world.

Hybrid Grafts Market Outlook by Category

By Product:

• Thoracic Aortic Graft
• Peripheral Vascular Graft

By End User:

• Hospitals
• Ambulatory Surgical Centers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube